UP

Pfizer-BioNTech is 70% effective against Delta variant

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

Pfizer-BioNTech jabs are 70% effective against the highly contagious Delta variant of COVID-19, according to a study conducted in Israel.

Axar.az reports citing foreign media that the results of Hebrew University's research on the vaccine's efficacy were published by the Israeli Public Broadcasting Corporation (KAN) on Sunday.

The new finding is compared to the 95% rate of effectiveness of the vaccine against earlier virus strains.

Delta variant, which was first detected in India, is said to be responsible for more than 90% of new COVID cases in Israel over the past two weeks.

Since December 2019, the pandemic has claimed over 3.97 million lives in 192 countries and regions, with some 183.74 million cases reported worldwide, according to US-based Johns Hopkins University.

Date
2021.07.05 / 17:41
Author
Axar.az
See also

Millions at risk as US ends AIDS funding - UNAIDS report

Smart hydrogel developed to heal chronic wounds faster

WHO pushes bold reforms, launching 3 by 35 initiative

Scientists discover new coronavirus

Azerbaijan performs first deceased donor organ transplants

Fifty countries affected by USAID freeze - WHO

Monkeypox case confirmed in Azerbaijan

WHO calls for international support to fund aid in Gaza

30 metapneumovirus cases reported in Kazakhstan

Human metapneumovirus epidemic reported in China

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla